Great Lakes Discovery to Facilitate University of Michigan Researcher to Pursue a Therapeutic Treatment for Systemic Inflammation

January 27, 2023

Great Lakes Discovery, the collaboration between Deerfield Management and the University of Michigan, will help facilitate Dr. David Markovitz M.D.’s lab to pursue a therapeutic treatment for systemic inflammation through the new exploratory biologics initiative.  David Markovitz is a Professor of Internal Medicine in the Division of Infectious Diseases who also has appointments in the programs in Cellular and Molecular Biology, Cancer Biology, and Immunology. This is the first project in the Great Lakes Discovery pipeline as well as the exploratory biologics initiative. 

Next
Next

Deerfield commits up to $130M to commercialize drug discovery at the University of Michigan